ClinicalTrials.gg
RecruitingNCT06398574Updated May 1, 2026

Effects of Dry Needling on the Behavior of the Shoulder Muscles

An interventional study of Real dry needling and Sham dry needling in Shoulder Pain, sponsored by University of Alcala. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by University of Alcala · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started May 2024; still recruiting 2 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The main objective of this study will be to evaluate the effects of the application of the dry needling technique on the activity of the rotator cuff muscles in the shoulder.

The evaluation of the effects of the application of the dry needling technique will be carried out in subjects with and without shoulder pain.To do this, muscle strength, possible thickness changes in the muscle and electromyographic activity will be measured before and immediately after the application of a dry needling technique.

Likewise, other variables will be measured such as the pressure pain threshold (PPT), pain with a Numeric Verbal Scale, kinesiophobia and catastrophism, the shoulder pain and disability index (SPADI) and the influence of expectations about dry needling.

02

Conditions studied

  • Shoulder Pain

Browse trials for

Keywords

  • Dry needling
  • Shoulder muscle strength
  • Surface electromyography
03

In context

Shoulder Pain

735 studies on the registry are indexed under Shoulder Pain; 167 are open to participants now.

This study's planned enrollment of 40 is below the median of 60 across 587 interventional studies indexed under Shoulder Pain.

Browse Shoulder Pain studies →

Lead sponsor

University of Alcala is the lead sponsor of 128 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subjects of legal age
  • Subjects without shoulder pain or with unilateral shoulder pain of > 3 months duration.
  • Have shoulder mobility of 90º of abduction and at least 30º of glenohumeral external rotation.

Exclusion criteria

Exclusion Criteria:

  • Have neck pain.
  • Whiplash
  • Having had trauma to the shoulder.
  • Having fibromyalgia.
  • Be pregnant.
  • Being afraid of needles.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Real dry needling

    With the subject lying supine, a dry needling technique will be applied to the infraspinatus muscle.

    Other: Real dry needling

  • Sham comparator
    Sham dry needling

    With the subject lying supine, a sham dry needling technique will be applied to the infraspinatus muscle, simulating the real procedure.

    Other: Sham dry needling

Interventions

  • OtherReal dry needling

    With the subject lying supine, a dry needling technique will be applied to the infraspinatus muscle. First, the most hyperalgesic point in the muscle will be located. Subsequently, Hong's fast-in and fast-out technique will be applied. Ten incisions will be made

  • OtherSham dry needling

    With the subject lying supine, a sham dry needling technique will be applied to the infraspinatus muscle. First, the most hyperalgesic point in the muscle will be located. Subsequently, Hong's fast-in and fast-out technique will be applied. Ten incisions will be made, simulating the real technique

06

What researchers measure

Primary outcomes

  1. Muscle strength

    The isometric strength will be assessed using a handheld dynamometer (Hand held dynamometer, MicroFET3; Hoggan Health Industries Inc.). The strength measures will included external rotation at 90° abduction in the prone position. The dynamometer will be placed just proximal to the just proximal to the styloid process of the wrist joint. Subjects will be asked to produce a 5-second maximal contraction. Muscular strength will be measured in kilograms

    Time frame: Change from Baseline at 15 minutes.

Secondary outcomes

  1. Muscle function

    Muscle function will be measured by an ultrasound scanner with a linear transducer with a frequency range of 6-16MHz (X6-16L, 5cm footprint) will be used. The unit of measurement used will be millimeters. Muscle thickness at rest and contraction will be measured. On the other hand, the percentage of change in thickness will be measured using the equation (Contraction thickness - Rest thickness) \* 100 / Rest thickness.

    Time frame: Change from Baseline at 15 minutes.

  2. Shoulder Pain

    Pain intensity will be measured using the Visual Analog Scale (VAS) for pain. The VAS is a 100-mm line, oriented horizontally, with one end representing "no pain" and ten the other end representing "worst pain." Subjects will be asked to rate their current pain with a mark on the scale.

    Time frame: Change from Baseline at 15 minutes.

  3. Disability

    Disability will be measured by Shoulder Pain and Disability Index (SPADI).The Spanish version of SPADI has high test-retest reliability (ICC 0.89-0.93).The clinically important minimum difference varies between 8 and 13.2. The minimum value is 0 and de maximum value is 100

    Time frame: Change from Baseline at 15 minutes.

  4. Pressure Pain Threshold (PPT)

    An algometer Wagner FPI 10-WA will be used to determine the PPT in infraespinatus muscle.

    Time frame: Change from Baseline at 15 minutes.

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Dec 2026, 31 months after the start.

Of 349 non-industry interventional studies with no phase under Shoulder Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 27. This study's planned 31 months is above that.

Counting every sponsor, half of 354 studies reached it within 11 months; a quarter within 4 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
May 1, 2024
First posted
May 3, 2024
StartActual
May 6, 2024
Primary completionEst.
Dec 20, 2026
CompletionEst.
Dec 20, 2026
Last update
May 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06398574
Responsible party
Prof. Dr. Daniel Pecos Martín (Professor, University of Alcala) — Principal investigator
First posted
May 3, 2024
Start date
May 6, 2024
Primary completion
Dec 20, 2026 (estimated)
Completion
Dec 20, 2026 (estimated)
Last update
May 1, 2026

Study contacts

Marina Ortega-Santamaria, PhD student
Contact
marinaortegasantamaria@gmail.com
(+34) 683 378 391
Centro Investigacion Fisioterapia y Dolor
Contact
Daniel Pecos-Martin, PhD
study chair · Alcala University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion